Javier Martin-Broto, MD, PhD

Fundación Jiménez Díaz University Hospital
Madrid, Madrid, Spain

Disclosure information not submitted.

Presentation(s):

• Paper 43 - BRIGIMADLIN VERSUS STANDARD-OF-CARE DOXORUBICIN AS FIRST-LINE TREATMENT IN PATIENTS WITH ADVANCED DEDIFFERENTIATED LIPOSARCOMA (DDLPS): BRIGHTLINE-1

  Friday, November 15, 2024
  9:00 AM – 10:00 AM PST

• Paper 64 - PREDICTIVE GENE SIGNATURE FOR TRABECTEDIN EFFICACY IN ADVANCED SOFT-TISSUE SARCOMA: A SPANISH GROUP FOR RESEARCH IN SARCOMA (GEIS) STUDY

  Friday, November 15, 2024
  4:00 PM – 5:00 PM PST